We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
But you have to ask yourself what is fundamentally different between now and a few months ago. From their business perspective you would have to say very little.
CBB I will be sitting on my hands too and hoping there will be a bounce.
When I first bought CLIN I also bought Dechra (dph). I put about the same money into each about 1600. CLIn is now worth 1200, DPH is 3400. It was DPH that looked expensive at the time, but it has been proven better quality, the difference may also be partly down to AIM vs the Main Board.
AIM is def more volatile so I am hopeful of being able to get out of Clin with a profit (as I could have done earlier this year).
£8 anyone?
and back in my pocket goes the top up money !..... i'm not even entertaining the idea if the price is north of 540, for me, this POS is trading in the region of it's worth, it's not undervalued in any way so going to take forever to get to where i need, to get what's owed
And Octopus investments is in with a new 5% disclosable position.
A4007035.....if the answer to your questions is yes, then the SP should take care of itself (high). Clearly the market is taking a different view at the moment.....while the market can be wrong it represents a lot of competing views.....unfortunately the company is heavily dependent on others (Eg Iovance) to deliver and they have not /are delayed.
Clin made a big investment in Proleukin using debt. There is a Growing risk this does not pay off. Clin will need to show its efforts to rejuvenate the drug is working.
Try not to think of the share price.
Think about the business itself and ask yourselves
- Are they cash generative
- Have management delivered on their promises in the main
- are they growing year on year
- Do they have a strong balance sheet
If you concentrate too much on the sp you'll suffer from tunnel vision.
If the above answers are all yes and continue to be yes the business will be successful. That is what matters here.
Investors have to be long.
can't say i blame you, this is now heading back down intot he region it may be worth me averaging down in the hopes of a smaller recovery will allow me out at what I'm owed
I hope you're wrong but good timing so far and wish you all the best :)
Hi chaps, I'm out now (at a fairly big loss!), i'll look to come back in in around 6-12 months when things should start looking more interesting- gla